ReviewReproductive sciences (Thousand Oaks, Calif.)2026
Biomaterials Empowering in New Era of Women's Healthcare System.
Review in Reproductive sciences (Thousand Oaks, Calif.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Women’s health encompasses complex biological, reproductive, and gynecological challenges that require innovative solutions. This review systematically examines emerging biomaterials—such as hydrogels, nanoparticles, and polymers—and their transformative role in drug delivery, tissue repair, and regenerative medicine for conditions like breast cancer, endometriosis, and pregnancy-related disorders. A comprehensive literature search was conducted across PubMed, Scopus, Web of Science, ScienceDirect, and Google Scholar using defined MeSH terms and Boolean operators, covering studies published between 2000 and 2024. The novelty of this review lies in its integrated perspective on biomaterials and their application in women’s health, highlighting advances in smart drug delivery systems and regenerative strategies for female reproductive organs. Key insights include improved therapeutic precision, minimally invasive approaches, and enhanced biocompatibility of biomaterials. Additionally, the review explores policy initiatives and persistent challenges such as gender bias in research and limited access to cutting-edge treatments. Finally, the integration of artificial intelligence (AI) with biomaterials is discussed as an emerging approach to optimize design, personalize therapies, and improve clinical outcomes, signaling a new era of women-focused healthcare innovation.
Indexed as
Identifiers
41870863What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.